Frequency of thalassemia, iron and glucose-6Phosphate dehydrogenase deficiency among turkish migrating nomad children in southern Iran

Acta Medica Iranica

Volumn 47, Issue 1, 2009, Pages 20-24

  Mehrabani, D ^a   Pasalar, M ^b   Afrasiabi, A R ^b   Mehravar, Z ^b   Reyhani, I ^b   Hamidi, R ^b   Karimi, M ^b,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

G6PD deficiency; Iron deficiency; Nomads; Southern iran; Thalassemia

Indexed keywords

FERRITIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN; IRON;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD SAMPLING; CHILD; CLINICAL FEATURE; DEVELOPING COUNTRY; ERYTHROCYTE COUNT; ETHNICITY; FAMILY HISTORY; FAVISM; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH STATUS; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDUSTRIAL AREA; IRAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MIGRATION; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SEX DIFFERENCE; TURKEY (REPUBLIC);

EID: 62549159994     PISSN: 00446025     EISSN: 00446025     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Farhud D, Sadighi H. Investigation of prevalence of thalassemia in Iran. Iran J Pubic Health 1997; 26: 1-2.
2. Nasab AH. Clinical and laboratory findings in the initial diagnosis of homozygous beta thalassemia on fars province, Iran. Br J Haematol. 1979; 43(1): 57-61.
3. Alebouyeh M. Pediatric hematology and oncology in Iran. Pediatr Hematol Oncol. 2005; 22(1): 1-9.
4. Caro JJ, Ward A, Green TC, Huybrechts K, Arana A, Wait S, Eleftheriou A. Impact of thalassemia major on patients and their families. Acta Haematol. 2002; 107(3): 50-7.
5. Noori-Daloii MR, Moazami N, Farhangi S, Atalay A, Geren IN, Akar L, Atalay EO, Cirakoglu B, Bermek E. Betathalassemia in Iran: a high incidence of the nonsense codon 39 mutation on the island of Queshm. Hemoglobin. 1994; 18(6): 449-53.
6. Karimi M, Yarmohammadi H, Farjadian S, Zeinali S, Moghaddam Z, Cappellini MD, Giordano PC. Beta-thalassemia intermedia from southern Iran: IVS-II-1 (G→A) is the prevalent thalassemia intermedia allele. Haemoglobin. 2002; 26(2): 147-54.
7. Yavarian M, Harteveld Cl, Batelaan D, Bernini LF, Giordano PC. Molecular spectrum of beta-thalassemia in the Iranian province of Hormozgan. Hemoglobin. 2001; 25(1): 3543.
8. Neishabury M, Oberkanins C, Moheb LA, Pourfatholuah AA, Kahrizi K, Keyhany E, Krugluger W, Najmabadi H. High prevalence of the-alpha 3.7 deletion among thalassemia patients in Iran. Hemoglobin. 2003; 27(1): 53-5.
9. Samavat A, Modell B. Iranian national thalassaemia screening programme. Br Med J. 2004; 329(7475): 1134-7.
10. Kazal LA Jr. Prevention of iron deficiency anemia in infants and toddlers. Am Fam Physician. 2002; 66(7): 1217-24.
11. Hedayat S, Rahbar S, Mahboodi E, Ghaffarpour M, Sobhi N. Favism in the Caspian littoral area of Iran. Trop Geog Med. 1971; 23: 149-57.
12. Donoso G, Hedayat H, Khayatian H. Favism, with special reference to Iran. Bull World Health Organ. 1969; 40(4): 513-9.
13. Wolf BH, Weening RS, Schutgens RB, Van Noorden CJ, Vogels IM, Nagelkerke NJ. Detection of glucose 6-Phosphate dehydrogenase deficiency in erythrocytes: A spectrophotometric assay and a fluorescent spot test compared with a cytochemical method. Clin Chim Acata. 1987; 168(2): 129-36.
14. General Haematology Task Force of the British Committee for Standards in Haematology. The laboratory diagnosis of haemoglobinopathies. Br J Haematol. 1998; 101: 783-92.
15. De Maeyer EM. Preventing and controlling iron deficiency anemia through primary health care. A guide for health administrators and programme managers. WHO, Geneva. 1989.
16. Milman N. Serum ferritin in Danes. Studies of iron status from infancy to old age, during blood donation and pregnancy. Int J Hematol. 1996; 63(2): 103-135.
17. Kadivar MR, Yarmohammadi H, Mirahmadizadeh AR, Vakili M, Karimi M. Prevalence of iron deficiency anemia in 6 months to 5 years old children in fars. Southern Iran. Med Sci Monit. 2003; 9(2): CR100-104.
18. Karimi M, Kadivar MR, Yarmohammadi H. Assesment of the prevalence of iron deficiency anemia, by serum ferritin, in pregnant women of southern Iran. Med Sci Monit. 2002; 8(7): CR488-492.
19. Jain S, Chopra H, Garg SK, Bhatnagar M, Singh JVl. Anemia in children: Early iron supplementation. India J Pediatr. 2000; 67(1): 19-21.
20. Caballo Roig N, Garcia P, Valdemoro M, del Castillo ML, Santos Tapia M, González Vargaz A, Arias Alvarez MA, Serna Saugán C, Merino JM, García Teresa MA, et al. The prevalence of anemia in children and adolescence of Madrid. Ann Esp Pediatr. 1993; 39(3): 219-22.
21. Lapeyssonnie L, Keyhan R. Proceedings of the first seminar of favism in Iran, Tehran, Food and Nutrition Institute of Iran: 1966; 36.
22. Ohkura K, Miyashita T, Nakajima H, Matsumoto H, Matsutomo K, Rahabar S, Hedayat S. Distribution of polymorphic traits in Mazandaranean and Guillanian in Iran. Hum Hered. 1984; 34: 27-39.
23. Elton P. Learning from low income countries: Thalassaemia screening in Iran provides evidence for programme in Lancashire. Br Med J. 2005; 330(7489): 478-479.
24. Christanson A, Streetly A, Darr A. Lessons from thalassemia screening in Iran. Br Med J. 2004; 329(7475): 11157.
25. Zakerinia M, Khojasteh HN, Ramzi M, Amirghafran Z, Tabei Z, Haghshenas M. Bone marrow transplantation for thalassemia in Shiraz. Transplant Proc. 1995; 27(5): 2659-60.
26. Ramzi M, Nourani H, Zakerinia M, Hamidian Jahromi AR. Hematopoietic stem cell transplantation for betathalassemia major: Experience in south of Iran. Transplant Proc. 2004; 36(8): 2509-10.
27. Khojasteh HN, Zakerinia M, Ramzi M, Haghshenas M. Results of allogeneic bone marrow transplantation in 90 patients at a University Hospital in southern Iran. Transplant Proc. 2000; 32(3): 597.